This small-cap company has found its watershed moment in Covid-19 pandemic

Kilpest India, one of the companies that have received ICMR's approval to produce RT-PCR kits for Covid-19 testing, has seen its share price more than double since April 1

From being a small-cap agro-chemical company to creating molecular diagnosis kits for Covid-19, Kilpest India’s hustle has been pivotal not only in its own journey but also in India’s fight against the coronavirus pandemic.

The company had been founded in 1972 by Ram Kuber Dubey to manufacture crop-protection and public health products, bio products, micronutrients and mix fertilisers. It operated as a maker of agri-products for almost four decades until 2008, when it diversified into biotechnology. Dubey continues to be chairman & managing director, but the company’s day-to-day operations are handled by his son Dhirendra. 

“Our agro chemicals business was running in